Economic menace of diabetes in India: a systematic review
- PDF / 800,176 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 2 Downloads / 237 Views
REVIEW ARTICLE
Economic menace of diabetes in India: a systematic review Sumit Oberoi 1 & Pooja Kansra 1 Received: 11 December 2019 / Accepted: 27 May 2020 # Research Society for Study of Diabetes in India 2020
Abstract Aim Diabetes mellitus is recognised as a major chronic pandemic disease that does not consider any ethnic and monetary background. There is a dearth of literature on the cost of diabetes in the Indian context. Therefore, the present study aims to capture the evidence from the literature on the cost of diabetes mellitus in India. Methods An extensive literature was reviewed from ACADEMIA, NCBI, PubMed, ProQuest, EBSCO, Springer, JSTOR, Scopus and Google Scholar. The eligibility criterion is based on ‘PICOS’ procedure, and only those studies which are available in the English language, published between 1999 and February 2019, indexed in ABDC, EBSCO, ProQuest, Scopus and peerreviewed journals are included. Results A total of thirty-two studies were included in the present study. The result indicates that the median direct cost of diabetes was estimated to be ₹18,890/- p.a. for the north zone, ₹10,585/- p.a. for the south zone, ₹45,792/- p.a. for the north-east zone and ₹8822/- p.a. for the west zone. Similarly, the median indirect cost of diabetes was ₹18,146/- p.a. for the north zone, ₹1198/- p.a. for the south zone, ₹18,707/- p.a. for the north-east and ₹3949/- p.a. for the west zone. Conclusion The present study highlighted that diabetes poses a high economic burden on individuals/households. The study directed the need to arrange awareness campaign regarding diabetes and associated risk factors in order to minimise the burden of diabetes. Keywords Diabetes . India . Economic menace . Costs and complications
Introduction ‘Diabetes is a metabolic disease characterised by hyperglycemia resulting from defects in insulin secretion, insulin action or both’ [1]. With rising pervasiveness globally, diabetes is conceded as a major chronic pandemic disease which does not consider any ethnic background and monetary levels both in developing and developed economies and has also been designated with the status of ‘public health priority’ in the majority of the countries [2, 3]. Individuals with Electronic supplementary material The online version of this article (https://doi.org/10.1007/s13410-020-00838-z) contains supplementary material, which is available to authorized users. * Sumit Oberoi [email protected] Pooja Kansra [email protected] 1
Mittal School of Business, Lovely Professional University, Phagwara, Punjab, India
diabetes are more susceptible to develop any of the associated complications, viz. macrovascular or microvascular. As a consequence, people experience frequent and exhaustive confrontation with the health care systems [4]. The treatment cost for diabetes and its associated complications exert an enormous economic burden both at the household and national levels [5–9]. In a developing nation like India, the majority of diabetes patients experience a substantial cost burden from
Data Loading...
